Literature DB >> 12471132

Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells.

Ali A Akhiani1, Jacques Pappo, Zita Kabok, Karin Schön, Wei Gao, Lennart E Franzén, Nils Lycke.   

Abstract

The regulatory roles of Th1 and Th2 cells in immune protection against Helicobacter infection are not clearly understood. In this study, we report that a primary H. pylori infection can be established in the absence of IL-12 or IFN-gamma. However, IFN-gamma, but not IL-12, was involved in the development of gastritis because IFN-gamma(-/-) (GKO) mice exhibited significantly less inflammation as compared with IL-12(-/-) or wild-type (WT) mice. Both IL-12(-/-) and GKO mice failed to develop protection following oral immunization with H. pylori lysate and cholera toxin adjuvant. By contrast, Th2-deficient, IL-4(-/-), and WT mice were equally well protected. Mucosal immunization in the presence of coadministered rIL-12 in WT mice increased Ag-specific IFN-gamma-producing T cells by 5-fold and gave an additional 4-fold reduction in colonizing bacteria, confirming a key role of Th1 cells in protection. Importantly, only protected IL-4(-/-) and WT mice demonstrated substantial influx of CD4(+) T cells in the gastric mucosa. The extent of inflammation in challenged IL-12(-/-) and GKO mice was much reduced compared with that in WT mice, indicating that IFN-gamma/Th1 cells also play a major role in postimmunization gastritis. Of note, postimmunization gastritis in IL-4(-/-) mice was significantly milder than WT mice, despite a similar level of protection, indicating that immune protection is not directly linked to the degree of gastric inflammation. Only protected mice had T cells that produced high levels of IFN-gamma to recall Ag, whereas both protected and unprotected mice produced high levels of IL-13. We conclude that IL-12 and Th1 responses are crucial for H. pylori-specific protective immunity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12471132     DOI: 10.4049/jimmunol.169.12.6977

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  66 in total

1.  Proinflammatory cytokine gene expression in the stomach correlates with vaccine-induced protection against Helicobacter pylori infection in mice: an important role for interleukin-17 during the effector phase.

Authors:  Carl-Fredrik Flach; Anna Karin Östberg; Anne-Therese Nilsson; Rene De Waal Malefyt; Sukanya Raghavan
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

2.  DC-derived IL-18 drives Treg differentiation, murine Helicobacter pylori-specific immune tolerance, and asthma protection.

Authors:  Mathias Oertli; Malin Sundquist; Iris Hitzler; Daniela B Engler; Isabelle C Arnold; Sebastian Reuter; Joachim Maxeiner; Malin Hansson; Christian Taube; Marianne Quiding-Järbrink; Anne Müller
Journal:  J Clin Invest       Date:  2012-02-06       Impact factor: 14.808

3.  Helicobacter pylori-specific CD4+ T cells home to and accumulate in the human Helicobacter pylori-infected gastric mucosa.

Authors:  Anna Lundgren; Christina Trollmo; Anders Edebo; Ann-Mari Svennerholm; B Samuel Lundin
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

4.  Emerging role of IL-23/IL-17 axis in H pylori-associated pathology.

Authors:  Roberta Caruso; Francesco Pallone; Giovanni Monteleone
Journal:  World J Gastroenterol       Date:  2007-11-14       Impact factor: 5.742

5.  Th immune response induced by H pylori vaccine with chitosan as adjuvant and its relation to immune protection.

Authors:  Yong Xie; Nan-Jin Zhou; Yan-Feng Gong; Xiao-Jiang Zhou; Jiang Chen; Si-Juan Hu; Nong-Hua Lu; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

Review 6.  Th17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm.

Authors:  Beverly R E A Dixon; Rafat Hossain; Rachna V Patel; Holly M Scott Algood
Journal:  Infect Immun       Date:  2019-10-18       Impact factor: 3.441

7.  Oral vaccination against Helicobacter pylori infection is not effective in mice with Fas ligand deficiency.

Authors:  Yaron Avitzur; Esther Galindo-Mata; Nicola L Jones
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

Review 8.  Exploring alternative treatments for Helicobacter pylori infection.

Authors:  Guadalupe Ayala; Wendy Itzel Escobedo-Hinojosa; Carlos Felipe de la Cruz-Herrera; Irma Romero
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

9.  CagY Is an Immune-Sensitive Regulator of the Helicobacter pylori Type IV Secretion System.

Authors:  Roberto M Barrozo; Lori M Hansen; Anna M Lam; Emma C Skoog; Miriam E Martin; Lucy P Cai; Yong Lin; Andreas Latoscha; Sebastian Suerbaum; Don R Canfield; Jay V Solnick
Journal:  Gastroenterology       Date:  2016-08-26       Impact factor: 22.682

Review 10.  Cytotoxic T cells in H. pylori-related gastric autoimmunity and gastric lymphoma.

Authors:  Mathijs P Bergman; Mario M D'Elios
Journal:  J Biomed Biotechnol       Date:  2010-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.